Ardent Health FY2025 EPS Estimate Lowered by Leerink Partnrs

Key Points

• Leerink Partners has reduced their fiscal year 2025 EPS estimate for Ardent Health from $2.01 to $1.75, indicating a significant downward adjustment in earnings expectations.
• Ardent Health recently reported a quarterly EPS of $0.52, exceeding the consensus estimate of $0.30, along with revenue of $1.65 billion which also surpassed expectations.
• Analyst ratings vary, with several analysts maintaining an "overweight" rating while others have issued lower target prices, leading to a consensus rating of "Moderate Buy" for the stock.

Ardent Health, Inc. (NYSE:ARDT - Free Report) - Investment analysts at Leerink Partnrs decreased their FY2025 EPS estimates for Ardent Health in a research note issued to investors on Wednesday, August 6th. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings per share of $1.75 for the year, down from their previous estimate of $2.01. The consensus estimate for Ardent Health's current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health's Q4 2025 earnings at $0.58 EPS, Q1 2026 earnings at $0.39 EPS, Q2 2026 earnings at $0.53 EPS, Q3 2026 earnings at $0.47 EPS, Q4 2026 earnings at $0.64 EPS, FY2026 earnings at $2.04 EPS, FY2027 earnings at $2.28 EPS and FY2028 earnings at $2.55 EPS.

Ardent Health (NYSE:ARDT - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.30 by $0.22. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.54 billion.

A number of other brokerages also recently issued reports on ARDT. Wall Street Zen raised shares of Ardent Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday. KeyCorp cut their price objective on shares of Ardent Health from $24.00 to $20.00 and set an "overweight" rating for the company in a research report on Thursday. Stephens reissued an "overweight" rating and set a $21.00 price objective on shares of Ardent Health in a research report on Tuesday, May 20th. Guggenheim boosted their price objective on shares of Ardent Health from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Friday, May 9th. Finally, Bank of America downgraded shares of Ardent Health from a "neutral" rating to an "underperform" rating and cut their price objective for the company from $15.50 to $14.60 in a research report on Wednesday, July 16th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $19.97.

Ardent Health Stock Performance

NYSE:ARDT traded up $0.40 during trading hours on Friday, reaching $11.87. The company had a trading volume of 497,421 shares, compared to its average volume of 540,261. The company has a current ratio of 2.13, a quick ratio of 1.98 and a debt-to-equity ratio of 0.66. Ardent Health has a 52 week low of $10.10 and a 52 week high of $20.72. The firm has a market cap of $1.70 billion and a price-to-earnings ratio of 6.56. The firm's 50 day moving average price is $12.68 and its 200-day moving average price is $13.47.

Institutional Trading of Ardent Health

Several large investors have recently made changes to their positions in the company. Oliver Luxxe Assets LLC lifted its position in Ardent Health by 1.5% in the second quarter. Oliver Luxxe Assets LLC now owns 87,639 shares of the company's stock valued at $1,197,000 after buying an additional 1,319 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Ardent Health in the 4th quarter valued at approximately $27,000. Geode Capital Management LLC raised its stake in shares of Ardent Health by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company's stock valued at $3,918,000 after acquiring an additional 1,769 shares during the period. Squarepoint Ops LLC lifted its holdings in shares of Ardent Health by 1.8% in the 4th quarter. Squarepoint Ops LLC now owns 101,798 shares of the company's stock worth $1,739,000 after acquiring an additional 1,798 shares during the last quarter. Finally, CWM LLC boosted its position in shares of Ardent Health by 990.6% during the 2nd quarter. CWM LLC now owns 2,203 shares of the company's stock worth $30,000 after purchasing an additional 2,001 shares during the period.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.